Detalhe da pesquisa
1.
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.
Cell
; 184(23): 5699-5714.e11, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735795
2.
Single-B cell analysis correlates high-lactate secretion with stress and increased apoptosis.
Sci Rep
; 14(1): 8507, 2024 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605071
3.
Microfluidic Approach to Resolve Simultaneous and Sequential Cytokine Secretion of Individual Polyfunctional Cells.
J Vis Exp
; (205)2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526129
4.
Single-cell deep phenotyping of cytokine release unmasks stimulation-specific biological signatures and distinct secretion dynamics.
Cell Rep Methods
; 3(7): 100502, 2023 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533643
5.
Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.
Vaccine
; 41(19): 3047-3057, 2023 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37037709
6.
Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus.
Cell Biosci
; 12(1): 86, 2022 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690803
7.
Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.
mSphere
; 7(1): e0067421, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35080470
8.
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.
Vaccine
; 40(32): 4453-4463, 2022 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697571
9.
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Nat Commun
; 13(1): 1251, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35273178
10.
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Nat Med
; 27(2): 279-288, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335322
11.
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Nat Med
; 27(6): 1113, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33958800